Longeveron LGVN Stock
Longeveron Price Chart
Longeveron LGVN Financial and Trading Overview
| Longeveron stock price | 0.8 USD |
| Previous Close | 0.82 USD |
| Open | 0.84 USD |
| Bid | 0.58 USD x 200 |
| Ask | 1.05 USD x 200 |
| Day's Range | 0.8 - 0.85 USD |
| 52 Week Range | 0.48 - 1.8 USD |
| Volume | 391.24K USD |
| Avg. Volume | 529.96K USD |
| Market Cap | 25.29M USD |
| Beta (5Y Monthly) | -0.382 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -1.14 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 7.15 USD |
LGVN Valuation Measures
| Enterprise Value | 9.92M USD |
| Trailing P/E | N/A |
| Forward P/E | -0.5231373 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 20.798521 |
| Price/Book (mrq) | 1.5362763 |
| Enterprise Value/Revenue | 8.158 |
| Enterprise Value/EBITDA | -0.459 |
Trading Information
Longeveron Stock Price History
| Beta (5Y Monthly) | -0.382 |
| 52-Week Change | -35.48% |
| S&P500 52-Week Change | 22.66% |
| 52 Week High | 1.8 USD |
| 52 Week Low | 0.48 USD |
| 50-Day Moving Average | 0.85 USD |
| 200-Day Moving Average | 0.75 USD |
LGVN Share Statistics
| Avg. Volume (3 month) | 529.96K USD |
| Avg. Daily Volume (10-Days) | 191.44K USD |
| Shares Outstanding | 30.15M |
| Float | 25.33M |
| Short Ratio | 5.19 |
| % Held by Insiders | 9.72% |
| % Held by Institutions | 14.08% |
| Shares Short | 2.15M |
| Short % of Float | 7.38% |
| Short % of Shares Outstanding | 6.80% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor | 1:10 |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | March 31, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | -1149.49% |
| Gross Margin | 65.13% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -67.41% |
| Return on Equity (ttm) | -135.17% |
Income Statement
| Revenue (ttm) | 1.22M USD |
| Revenue Per Share (ttm) | 0.06 USD |
| Quarterly Revenue Growth (yoy) | 4.50% |
| Gross Profit (ttm) | 792K USD |
| EBITDA | -21624000 USD |
| Net Income Avi to Common (ttm) | -22429000 USD |
| Diluted EPS (ttm) | -1.14 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 15.76M USD |
| Total Cash Per Share (mrq) | 0.51 USD |
| Total Debt (mrq) | 748K USD |
| Total Debt/Equity (mrq) | 4.67 USD |
| Current Ratio (mrq) | 3.879 |
| Book Value Per Share (mrq) | 0.521 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -18318000 USD |
| Levered Free Cash Flow (ttm) | -10452625 USD |
Profile of Longeveron
| Country | United States |
| State | FL |
| City | Miami |
| Address | Life Science & Technology Park |
| ZIP | 33136 |
| Phone | 844 470 2550 |
| Website | https://longeveron.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 38 |
Longeveron Inc., a clinical stage biotechnology company, develops cellular therapies for aging-related and life-threatening conditions in the United States. Its lead investigational product is the LOMECEL-B, an allogeneic mesenchymal stem cell formulation sourced from the bone marrow of young and healthy adult donors which is in phase 3 clinical trial to treat hypoplastic left heart syndrome; completed phase 2a clinical trial to treat Alzheimer's disease, as well as in phase 2b clinical trial to treat aging frailty. The company was incorporated in 2014 and is headquartered in Miami, Florida.
Q&A For Longeveron Stock
What is a current LGVN stock price?
Longeveron LGVN stock price today per share is 0.8 USD.
How to purchase Longeveron stock?
You can buy LGVN shares on the Tech Market Small exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Longeveron?
The stock symbol or ticker of Longeveron is LGVN.
Which industry does the Longeveron company belong to?
The Longeveron industry is Biotechnology.
How many shares does Longeveron have in circulation?
The max supply of Longeveron shares is 31.6M.
What is Longeveron Price to Earnings Ratio (PE Ratio)?
Longeveron PE Ratio is now.
What was Longeveron earnings per share over the trailing 12 months (TTM)?
Longeveron EPS is -1.14 USD over the trailing 12 months.
Which sector does the Longeveron company belong to?
The Longeveron sector is Healthcare.
Longeveron LGVN included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
25587.04 USD — |
-2.21
|
13.85B USD — | 25513.26 USD — | 25882.57 USD — | — - | 13.85B USD — |
|
US Tech Health Care
IXHC
US
|
1184.66 USD — |
+0.75
|
— — | 1174.72 USD — | 1192.68 USD — | — - | — — |
- {{ link.label }} {{link}}